Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 10532986
Cyclic compound acting as PDE4 inhibitor
granted -
US 10532109
Peptide-DNA chimeras for treatment of HER overexpressing cancers
granted -
US 10532106
Bicyclic peptide ligands specific for MT1-MMP
granted -
US 10532079
Extracts and beverages containing 2,5-piperazinedione, 3,6-bis(phenylmethyl)-, (3S,6S)-
granted -
US 10532059
Steroid hormone pharmaceutical composition
granted -
US 10533227
Compositions, kits, and methods for identification, assessment, prevention and therapy of breast and ovarian cancer
granted -
US 10532056
Therapeutic compositions, combinations, and methods of use
granted -
US 10532040
Methods of treating cancer with herbacetin
granted -
CA 3105778
POLYTHERAPIE AVEC DES ANTAGONISTES DU CGRP ET DES DERIVES DE CLOSTRIDIUM
granted -
US 10525052
Abuse-deterrent drug formulations
granted -
US 10526403
Anti-activin A antibodies and uses thereof
granted -
US 10526297
Benzylideneguanidine derivatives and therapeutic use for the treatment of protein misfolding diseases
granted -
US 10526346
Histone deacetylase inhibitors
granted -
US 10526400
Humanized pertussis antibodies and used thereof
granted -
US 10526414
Use of anti-semaphorin-4D antibodies in combination with an immune modulating therapy to inhibit tumor growth and metastases
granted -
US 10525106
Angiopoietin-based interventions for treating cerebral malaria
granted -
US 10526576
Compositions and methods for differentiating stem cells into cell populations comprising beta-like cells
granted -
US 10525046
Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
granted -
US 10526373
Peptide showing melanin generation-promoting activity and use thereof
granted -
US 10526397
Non-immunogenic single domain antibodies
granted -
US 10526370
Pentapeptide associated with integrin receptor alpha vbeta3
granted -
US 10526359
Thiosaccharide mucolytic agents
granted -
US 10526344
Amino acid acylation reagents and methods of using the same
granted -
US 10526330
JAK kinase inhibitor compounds for treatment of respiratory disease
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.